TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 82 filers reported holding TRINITY BIOTECH PLC in Q1 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $95,000 | -79.1% | 15,900 | -53.7% | 0.01% | -81.2% |
Q3 2016 | $454,000 | +131.6% | 34,373 | +99.0% | 0.05% | +77.8% |
Q2 2016 | $196,000 | -5.3% | 17,273 | -2.8% | 0.03% | -6.9% |
Q1 2016 | $207,000 | -1.0% | 17,773 | 0.0% | 0.03% | -9.4% |
Q4 2015 | $209,000 | +43.2% | 17,773 | +39.1% | 0.03% | +52.4% |
Q3 2015 | $146,000 | -71.8% | 12,773 | -55.5% | 0.02% | -71.2% |
Q2 2015 | $518,000 | -6.2% | 28,684 | 0.0% | 0.07% | -5.2% |
Q1 2015 | $552,000 | -14.6% | 28,684 | -22.2% | 0.08% | -18.9% |
Q4 2014 | $646,000 | -79.2% | 36,884 | -78.3% | 0.10% | -78.3% |
Q3 2014 | $3,099,000 | +58.1% | 169,624 | +99.3% | 0.44% | +68.7% |
Q2 2014 | $1,960,000 | +25.4% | 85,091 | +31.9% | 0.26% | +23.9% |
Q1 2014 | $1,563,000 | +35.2% | 64,500 | +40.2% | 0.21% | +10.0% |
Q4 2013 | $1,156,000 | +67.5% | 46,000 | +12.4% | 0.19% | +28.4% |
Q2 2013 | $690,000 | +44.4% | 40,929 | +44.6% | 0.15% | +66.3% |
Q1 2013 | $478,000 | – | 28,314 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 657,100 | $11,072,000 | 4.49% |
GOLDMAN CAPITAL MANAGEMENT INC | 343,000 | $5,780,000 | 3.30% |
Lyon Street Capital, LLC | 368,858 | $6,215,257,000 | 3.08% |
JAY JEFFREY R | 163,140 | $2,749,000 | 2.17% |
Adirondack Research & Management Inc. | 161,507 | $2,721,000 | 2.03% |
Park West Asset Management LLC | 448,415 | $7,556,000 | 0.89% |
Benchmark Capital Advisors | 51,600 | $869,000 | 0.67% |
SHEPHERD KAPLAN KROCHUK, LLC | 166,034 | $2,797,000 | 0.55% |
HEARTLAND ADVISORS INC | 1,569,699 | $26,449,000 | 0.49% |
WOODMONT INVESTMENT COUNSEL LLC | 86,682 | $1,461,000 | 0.49% |